These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11140049)

  • 1. Amiodarone: the AHA's new drug of choice for victims of ventricular arrhythmias.
    Erich J
    Emerg Med Serv; 2000 Oct; 29(10):22. PubMed ID: 11140049
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous amiodarone.
    Med Lett Drugs Ther; 1995 Dec; 37(963):114-5. PubMed ID: 7500909
    [No Abstract]   [Full Text] [Related]  

  • 3. Ventricular arrhythmias and the use of antiarrhythmic drugs after cardiovascular surgery.
    Olshansky B
    Am J Manag Care; 1998 Nov; 4(11):1603-10; quiz 1611-12. PubMed ID: 10338906
    [No Abstract]   [Full Text] [Related]  

  • 4. Amiodarone administration for refractory ventricular fibrillation or pulseless ventricular tachycardia.
    Rosini JM; Zizza L
    Nursing; 2016 Oct; 46(10):61-2. PubMed ID: 27654444
    [No Abstract]   [Full Text] [Related]  

  • 5. Amiodarone for ventricular tachycardia after coronary artery bypass grafting.
    Wood MK
    Ann Thorac Surg; 1996 Jun; 61(6):1874. PubMed ID: 8651814
    [No Abstract]   [Full Text] [Related]  

  • 6. An overview of antiarrhythmic drug management of electrical storm.
    Kowey PR
    Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction: What does the crystal ball tell you?
    Auer J; Lamm G
    Crit Care Med; 2011 Jan; 39(1):204-5. PubMed ID: 21178539
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous amiodarone for treating acute life threatening arrhythmias.
    Votey SR; Herbert ME
    West J Med; 1998 Mar; 168(3):183. PubMed ID: 9549418
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous amiodarone. Another option in the acute management of sustained ventricular tachyarrhythmias.
    Naccarelli GV; Jalal S
    Circulation; 1995 Dec; 92(11):3154-5. PubMed ID: 7586296
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.
    Rea RS; Kane-Gill SL; Rudis MI; Seybert AL; Oyen LJ; Ou NN; Stauss JL; Kirisci L; Idrees U; Henderson SO
    Crit Care Med; 2006 Jun; 34(6):1617-23. PubMed ID: 16614583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous amiodarone for ventricular arrhythmias: overview and clinical use.
    Gonzalez ER; Kannewurf BS; Ornato JP
    Resuscitation; 1998; 39(1-2):33-42. PubMed ID: 9918445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.
    Van Herendael H; Dorian P
    Vasc Health Risk Manag; 2010 Aug; 6():465-72. PubMed ID: 20730062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of amiodarone in the management of patients with cardiac arrest.
    Franks AM; Watterson KS
    J Ark Med Soc; 2000 Dec; 97(6):196-9. PubMed ID: 12876823
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous antiarrhythmic drug therapy in the resuscitation from refractory ventricular arrhythmias.
    Kudenchuk PJ
    Am J Cardiol; 1999 Nov; 84(9A):52R-55R. PubMed ID: 10568660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
    Am J Cardiol; 1999 Nov; 84(9A):46R-51R. PubMed ID: 10568659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
    Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM
    Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility and adverse effects of amiodarone therapy.
    Roberts M
    AACN Adv Crit Care; 2010; 21(4):333-8; quiz 339-40. PubMed ID: 21045568
    [No Abstract]   [Full Text] [Related]  

  • 18. Amiodarone in the new AHA guidelines for ventricular tachyarrhythmias.
    Caron MF; Kluger J; White CM
    Ann Pharmacother; 2001 Oct; 35(10):1248-54. PubMed ID: 11675855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmias.
    Nolan PE
    Pharmacotherapy; 1997; 17(2 Pt 2):65S-75S; discussion 89S-91S. PubMed ID: 9085342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group.
    Scheinman MM; Levine JH; Cannom DS; Friehling T; Kopelman HA; Chilson DA; Platia EV; Wilber DJ; Kowey PR
    Circulation; 1995 Dec; 92(11):3264-72. PubMed ID: 7586313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.